Authors


Sanjay R. Patel, MD, MS

Latest:

Promising Developments in Pharmaceutical Treatments for Sleep Apnea: Sanjay R. Patel, MD, MS

The director of the Center for Sleep and Cardiovascular Outcomes Research at University of Pittsburgh talked about a novel pharmacologic treatment that shows potential as an alternative to continuous positive airway pressure for sleep apnea. [WATCH TIME: 5 minutes]


Krystyn J. Van Vliet, PhD

Latest:

Bridging Engineering and Neuroscience in the Creation of Artificial Axons for Myelination Research: Krystyn J. Van Vliet, PhD & Anna Jagielska, PhD, MSc

The professor of materials science and engineering at Cornell University and chief executive officer at Artificial Axon Labs talked about the development of artificial axons through 3D printing. [WATCH TIME: 6 minutes]


Thomas Scammell, MD

Latest:

Unmet Needs in Narcolepsy and Clinical Pearls

Neurology experts discuss the unmet needs in narcolepsy treatment and share clinical pearls from their experiences.


David Brumbaugh, MD

Latest:

Improving Quality of Life, Digestive Health in Duchenne Muscular Dystrophy: David Brumbaugh, MD

The associate professor of pediatrics at the University of Colorado School of Medicine talked at the 2023 MDA Conference about how digestive health impacts patients with Duchene Muscular Dystrophy. [WATCH TIME: 4 minutes]


Andrew Barerrto, MD, MS

Latest:

Efficacy of Adjunctive Therapies for Acute Ischemic Stroke Based on Phase 3 MOST Trial: Opeolu Adeoye, MD, MS; Andrew Barerrto, MD, MS

The professor of emergency medicine at Washington University in St. Louis and associate professor of neurosurgery at UTHealth Houston talked about results from the phase 3 MOST trial assessing argatroban and eptifibatide in acute ischemic stroke. [WATCH TIME: 3 minutes]


Yuri Maricich, MD, MBA

Latest:

The Need for More Sleep Education in Medicine: Yuri Maricich, MD, MBA

The internal medicine physician and chief medical officer and head of development at Pear Therapeutics offered his perspective on the current focus that is given to sleep in clinical care and the lack of education on interventions. [WATCH TIME: 2 minutes]


Susan Abushakra, MD

Latest:

Future Plans for ALZ-801 in Homo- and Heterozygous Populations: Susan Abushakra, MD

The chief medical officer at Alzheon provided perspective on the next steps for ALZ-801 following a successful phase 2 study of patients with APOE ε4/4 or APOE ε3/4 genotype. [WATCH TIME: 2 minutes]


Ivana Rubino, PhD, BSc

Latest:

Adapting to Changes in Alzheimer Disease Trials and Therapeutics: Ivana Rubino, PhD, MSc

The head of Global Medical for Neuropsychiatry and Alzheimer Disease at Biogen commented on challenges with conducting effective trials for Alzheimer disease and the potential research opportunities with newly approved novel treatments. [WATCH TIME: 6 minutes]


Dana Allwein

Latest:

COVID-19’s Effect on the Brain

As many as 1 in 3 infected with COVID-19 have longer-term neurological or mental health symptoms.


Joshua Katz, MD

Latest:

Disease-Modifying Therapies and COVID-19 Antibody Response: Joshua Katz, MD

The chairman of the Clinical Advisory Committee of the New England Chapter of the National MS Society addressed the role DMTs play in patient response to the COVID-19 vaccine.


Svetlana P. Eckert, MD

Latest:

Significance of Evusheld’s Effect in Multiple Sclerosis: Svetlana P. Eckert, MD

The clinical assistant professor of neurology at Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, New York, talked about her presentation on Evusheld at the 2023 ACTRIMS Forum. [WATCH TIME: 5 minutes]


Yann Le Guen, PhD

Latest:

Realistic Views for Developing APOE-Targeted Gene Therapies for Alzheimer Disease: Yann Le Guen, PhD

The assistant director of computational biology at Stanford University discussed where the Alzheimer disease community stands on gene therapies that target APOE, and whether missense variants will play a role. [WATCH TIME: 4 minutes]


Clarisse Goas MSN, APRN-CNP

Latest:

Using Practical Training to Enhance Movement Disorder Care: Clarisse Goas MSN, APRN-CNP

The movement disorders nurse practitioner at The Ohio State University Wexner Medical Center talked about a meeting that equips nurse practitioners and physician assistants to improve movement disorder patient care. [WATCH TIME: 5 minutes]


Andrew Smith, MD

Latest:

Emerging Approaches to the Treatment of Multiple Sclerosis

Experts share insights on the latest innovations in multiple sclerosis research, in highlights from a recent State of the Science SummitTM, presented by Neurology Live®.


Jeffrey Dunn, MD, Professor of Clinical Neurology and Chief of Neuroimmunology, Neurology at Stanford University

Latest:

Emerging Multiple Sclerosis Treatments

From Standard-of-Care Injectables to Next-Generation S1P Receptor Modulators, Newer Treatments Offer Patients Options


Andréa Merriam

Latest:

Shining a Light on Movement Disorders, Advocating for Awareness and Access to Care: Andréa Merriam & Larry Gifford

The chief executive officer at Parkinson & Movement Disorder Alliance and the president at PD Avengers discussed the importance of awareness in movement disorders and the challenges that patients still face in getting access to treatments for improved quality of life. [WATCH TIME: 12 minutes


Debra Miller

Latest:

Helping to Expand Global Care for the Duchenne Muscular Dystrophy Patient Community: Debra Miller

The chief executive officer and founder at CureDuchenne discussed efforts to bring specialized physical therapy and infrastructure support to underserved regions to improve care for patients impacted by Duchenne worldwide. [WATCH TIME: 5 minutes]


Paul Edison, MD, PhD

Latest:

Potential Cognitive Benefits of Using GLP-1 Analogs for Alzheimer Disease Treatment: Paul Edison, MD, PhD

The professor of neuroscience at Imperial College London talked about results from a study assessing a glucagon-like peptide-1 analogue, liraglutide, in patients with Alzheimer disease. [WATCH TIME: 5 minutes]


Torge Rempe, MD

Latest:

The State of Biomarkers in Multiple Sclerosis

As the field of MS care turns its sights on addressing progressive disease, the need for more biomarkers of disease activity and therapeutic target engagement is perhaps greater than ever.


Patricia Clark, CNP

Latest:

Improving Medication Management and Education of Parkinson Disease in Hospital Settings: Patricia Clark, CNP

The nurse practitioner at the Cleveland Clinic talked about findings from a recent study focused on enhancing medication management and education for patients with Parkinson disease. [WATCH TIME: 5 minutes]


Robert G. Holloway, MD, MPH

Latest:

AUPN Leadership Minute Episode 22: Sharing Leadership: How to Select Vice-Chairs

Episode 23 of the AUPN Leadership Minute features Donald S. Higgins, Jr., MD, of the VHA and Albany Medical College; and Robert Holloway, MD, MPH, of University of Rochester School of Medicine and Dentistry. [WATCH TIME: 6 minutes]


John Michael Schreiber, MD

Latest:

Insights From the Pediatric Epilepsy Research Consortium on Advancing Genetic Testing

A duo of experts discussed the importance of addressing barriers such as provider comfort, access to genetic counselors, and insurance coverage to reduce diagnostic latency and standardize genetic testing for epilepsy. [WATCH TIME: 5 minutes]


Asaff Harel, MD

Latest:

Asaff Harel, MD: Risk Factors for Severe COVID-19 Infection in Multiple Sclerosis

The neurologist at Lenox Hill Hospital detailed the findings of his observational study that looked at patterns of COVID-19 infections in patients with multiple sclerosis.


Sharon Fekrat, MD

Latest:

Using Artificial Intelligence and Retinal Imaging to Detect Neurodegenerative Diseases Early: Sharon Fekrat, MD

The professor of ophthalmology and neurology at Duke University School of Medicine talked about a recent published study on using artificial intelligence and retinal scans to detect mild cognitive impairment in neurodegenerative diseases including Alzheimer disease. [WATCH TIME: 7 minutes]


Eric Olson, MD

Latest:

Raising Awareness on Insomnia, Asking Patients About Their Sleep: Eric Olson, MD

In honor of Insomnia Awareness Night, the president of the American Academy of Sleep Medicine board of directors talked about increasing awareness of the sleep disorder for the clinical and patient community. [WATCH TIME: 6 minutes]


Anna Castagna, MD

Latest:

The Need for Flexibility and Patient-Centered Approaches in Clinical Trials for Cervical Dystonia: Anna Castagna, MD

The consultant neurologist at Fondazione Don Carlo Gnocchi ONLUS stressed how new clinical trial designs for cervical dystonia should incorporate more flexible and patient-centered approaches, including new measurement scales and the use of technology. [WATCH TIME: 5 minutes]


Tarun Singhal, MD, MBBS

Latest:

Promising Nasal Administration Treatment for Non-Active Secondary Progressive MS: Tarun Singhal, MD, MBBS

The director of the PET Imaging Program in Neurologic Diseases at Brigham and Women’s Hospital talked about nasal administration of foralumab that shows promise in treating patients with non-active secondary progressive MS. [WATCH TIME: 5 minutes]


Neel Fotedar, MD

Latest:

Investigating Limb Swelling in Patients With Dravet Syndrome: Mandy Alhajj, DO, James Dolbow, DO & Neel Fotedar, MD

A trio of experts from university hospitals discussed a study that aimed to uncover the prevalence and associations of limb swelling in patients with Dravet syndrome in hopes of improving care. [WATCH TIME: 5 minutes]


Elyse Stock, MD

Latest:

Collecting Drug-Drug Interaction Data on Rimegepant: Elyse Stock, MD

The chief medical officer of Biohaven Pharmaceuticals discussed the findings of an assessment of rimegepant (Nurtec ODT) exposure with concomitant administration of inhibitors of P-gp and BCRP transporters.


Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP

Latest:

Advice for Advanced Practice Providers in Managing Sleep Disorders

Advanced practice practitioners share final pearls with their colleagues for the management of sleep disorders.

© 2025 MJH Life Sciences

All rights reserved.